Expression Analysis of Protein Inhibitor of Activated STAT in Inflammatory Demyelinating Polyradiculoneuropathy.
Adult
Aged
Bayes Theorem
Biomarkers
Disease Management
Disease Susceptibility
Female
Gene Expression Regulation
Guillain-Barre Syndrome
/ diagnosis
Humans
Male
Middle Aged
Multigene Family
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
/ diagnosis
Prognosis
Protein Inhibitors of Activated STAT
/ genetics
ROC Curve
AIDP
CIDP
PIAS
inflammatory demyelinating polyradiculoneuropathy
protein inhibitor of activated STAT
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2021
2021
Historique:
received:
10
02
2021
accepted:
21
04
2021
entrez:
31
5
2021
pubmed:
1
6
2021
medline:
1
10
2021
Statut:
epublish
Résumé
Protein inhibitors of activated STAT (PIAS) are involved in the regulation of the JAK/STAT signaling pathway and have interactions with NF-κB, p73 and p53. These proteins regulate immune responses; therefore dysregulation in their expression leads to several immune-mediated disorders. In the present study, we examined expression of
Identifiants
pubmed: 34054823
doi: 10.3389/fimmu.2021.659038
pmc: PMC8149797
doi:
Substances chimiques
Biomarkers
0
Protein Inhibitors of Activated STAT
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
659038Informations de copyright
Copyright © 2021 Ghafouri-Fard, Hussen, Nicknafs, Nazer, Sayad and Taheri.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Neuroimmunol. 2001 Jun 1;116(2):226-32
pubmed: 11438178
Blood. 2006 Feb 1;107(3):1085-91
pubmed: 16223771
Science. 1994 Apr 1;264(5155):95-8
pubmed: 8140422
J Biol Chem. 2007 Mar 30;282(13):9358-9363
pubmed: 17277312
J Inflamm Res. 2018 Dec 06;11:457-463
pubmed: 30584347
J Biol Chem. 2003 Jun 13;278(24):21327-30
pubmed: 12716907
Oncogene. 2006 Oct 30;25(51):6758-80
pubmed: 17072327
Semin Neurol. 2012 Jul;32(3):187-95
pubmed: 23117943
Trends Immunol. 2010 May;31(5):199-204
pubmed: 20181527
Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10626-31
pubmed: 9724754
Tumour Biol. 2017 Jul;39(7):1010428317719869
pubmed: 28859543
Eur Neurol. 2001;45(3):133-9
pubmed: 11306855
Ann Rheum Dis. 2004 Nov;63 Suppl 2:ii67-ii71
pubmed: 15479876
Nat Immunol. 2004 Sep;5(9):891-8
pubmed: 15311277
J Immunol. 2017 Jul 15;199(2):559-569
pubmed: 28607111
Nat Rev Immunol. 2005 Aug;5(8):593-605
pubmed: 16056253
J Mol Neurosci. 2020 Jun;70(6):945-952
pubmed: 32036580
Acta Neuropathol. 2015 Oct;130(4):445-68
pubmed: 26264608
Immunol Rev. 2014 Sep;261(1):84-101
pubmed: 25123278
Neurology. 1991 May;41(5):617-8
pubmed: 2027473
Science. 1997 Dec 5;278(5344):1803-5
pubmed: 9388184
J Int Med Res. 2020 Mar;48(3):300060520904842
pubmed: 32223661
J Cell Biochem. 2019 Aug;120(8):12937-12942
pubmed: 30861611
Immunology. 2013 May;139(1):1-10
pubmed: 23347175
Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1879-84
pubmed: 12571365
Front Immunol. 2018 Oct 26;9:2392
pubmed: 30416501
Transplant Proc. 2020 Jan - Feb;52(1):414-418
pubmed: 31870601
Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):2872-7
pubmed: 11867732